Abstracts

Citation

M Nikanjam, Edmund Capparelli, Pharm.D., Brian Robbins, Ph.D., Jorge Pinto, M.D., D.Sc., Ram Yogev, M.D., Carmelita Alvero, Paul Palumbo, M.D., Michael Hughes, Ph.D., John H. Rodman, Pharm.D., Ellen Gould Chadwick, M.D. Lopinavir population pharmacokinetic model and dose simulation predicts rapid increase in exposure for HIV-infected infants initiating therapy at <6 months of age (IMPAACT/PACTG P1030). Presented at: 16th Conference on Retroviruses & Opportunistic Infections.

Citation

Andrew A. Wiznia, M.D., Pearl Samson, M.S., Edward P. Acosta, Pharm.D., Hedy Teppler, M.D., Barney S. Graham, M.D., Ph.D., Terence Fenton, Ed.D., Edward Handelsman, M.D., Carol J. Worrell, M.D., Sharon Appelbaum Nachman, M.D. Safety and Efficacy of Raltegravir (RAL) in Pediatric HIV Infection. Preliminary analysis from IMPAACT P1066. Presented at: 16th Conference on Retroviruses & Opportunistic Infections.

Citation

Jessica D. Church, Anthony Mwatha, Laura A. Guay, M.D., M. Thigpen, Philippa Musoke, MB ChB, C. Eure, M. McConnell, Mary Glenn Fowler, M.D., M.P.H., Brooks Jackson, M.D., M.B.A., Susan H. Eshleman, M.D., PH.D. Predictors of nevirapine resistance in Ugandan infants who were HIV-infected despite single dose nevirapine prophylaxis. Presented at: 16th Conference on Retroviruses & Opportunistic Infections.

Citation

Russell B. Van Dyke, M.D., Gonzague A. Jourdain, M.D., Nicole Ngo-Giang-Huong, Pharm.D., Ph.D., Lisa M. Frenkel, M.D., Paula Britto, M.S., Anuvat Roongpisuthipong, M.D., Prapap Yuthavisuthi, M.D., Sinart Prommas, M.D., Thanyawee Puthanakit, M.D., M.H.S. A Phase II Study of the Incidence of Nevirapine Resistance Mutations (NR) in HIV-Infected Thai Women Receiving a Single Intrapartum (IP) Dose of NVP (SDNVP) Followed by a Postpartum (PP) Tail of ZDV/ddI or ZDV/ddI/LPV/r (PACTG/IMPAACT P1032). Presented at: 16th Conference on Retroviruses & Opportunistic Infections.

Citation

Charles Debeaux Mitchell, M.D., George D. McSherry, M.D., Avy Violari, M.D., Mark F. Cotton, MMED, Ph.D., MB ChB, Raziya Bobat, M.D., Patrick Jean-Philippe, M.D., Sue Kim, Sharon Appelbaum Nachman, M.D. Primary Isoniazid prophylaxis did not protect against Tuberculosis or Latent TB infection in HIV-exposed, uninfected infants in South Africa. Presented at: 16th Conference on Retroviruses & Opportunistic Infections.

Citation

Patricia M. Flynn, M.D., M.S., Mark Mirochnick, M.D., David E. Shapiro, Ph.D., Arlene D. Bardeguez, M.D., M.P.H., F.A.C.O.G., Alice Huang, Ph.D., Susan A. Fiscus, Ph.D., Koen Van Rompay, D.V.M., Ph.D., James F. Rooney, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Heather D. Watts, M.D., Patrick Jean-Philippe, M.D. Single Dose Tenofovir Disoproxil Fumarate (TDF) with and without Emtricitabine (FTC) in HIV-1 Infected Pregnant Women and their Infants: Pharmacokinetics (PK) and Safety. Presented at: 16th Conference on Retroviruses & Opportunistic Infections.

Citation

Nirun Vanprapar, M.D., M.Sc., Tim Roy Cressey, B.Sc., Ph.D., Kulkanya Chokephaibulkit, M.D., Edmund Capparelli, Pharm.D., Virat Sirisanthana, Suchat Hongsiriwon, M.D., Kenneth McIntosh, M.D., Wasana Prasitsuebsai, M.D., Petronella Muresan, M.S., Ram Yogev, M.D. A Novel Chewable Pediatric Fixed-Dose Combination (FDC) of Stavudine (d4T), Lamivudine (3TC), Nevirapine (NVP): Pharmacokinetics and Safety in HIV-Infected Thai Children. Presented at: 16th Conference on Retroviruses & Opportunistic Infections.

Citation

Nishaki Mehta, Margaret McManus, B.S., Robert Lin, M.D., Mohan Somasundaran, Ram Yogev, M.D., Ellen Gould Chadwick, M.D., Katherine Luzuriaga, M.D. Early Suppression of Viral Replication Preserves Measles-Specific Memory B Cells in Children. Presented at: 16th Conference on Retroviruses & Opportunistic Infections.

Citation

G. M. Ellis, Jane Hitti, M.D., M.P.H., L. Frenkel. Increased Resistance to Lamivudine Detected in HIV-Positive Pregnant Women Discontinuing Zidovudine (AZT), Lamivudine (3TC), and Nelfinavir (NFV): Results of PACTG 1022. Presented at: 16th Conference on Retroviruses & Opportunistic Infections.

Citation

Donald Campbell, Ph.D., Nancy Tustin, M.L.T., (ASCP), Eric Riedel, B.S., Richard Tustin, III, J. Taylor, Steven D. Douglas, M.D. Cryopreservation Decreases PD-1/PD-L1 Co-Inhibitory Expression on PBMC-Derived T Cells and Monocytes. Presented at: 16th Conference on Retroviruses & Opportunistic Infections.